The Boeing Company (BCO)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 166.20 |
|---|---|
| 52-week range | 153.94 – 217.30 |
| Return, 1 month / 3 months | −6.4% / −9.1% |
| Return, 1 year / 3 years | −11.6% / −2.9% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 30.8% |
| Worst drawdown (1 year) | -23.5% |
| Average daily value traded | 0.86M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Boeing is an aerospace company that designs and builds commercial jet airliners for airlines around the world, along with military aircraft, rotorcraft, satellites, missile systems and space hardware for government and defence customers. It also provides related services such as maintenance, parts, training and engineering support. The company is based in the United States and serves airlines, armed forces and space agencies across many countries.
On this site The Boeing Company appears as a stock on the XETRA Stock Exchange (Germany), code BCO, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Boeing Company (BCO) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 166.20 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 396 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.6% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.9% | ||
| From 52-week high | -23.1% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.1% | ||
| 6-month return | -16.9% | ||
| 12-month return, skipping the last month | -5.6% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.5% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.86M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | −6.4% |
| 3 months | −9.1% |
| 6 months | −16.9% |
| 1 year | −11.6% |
| 3 years | −2.9% |
| 5 years | −9.5% |
Signals
| 50-day / 200-day average | 175.64 / 188.73 |
|---|---|
| Golden / death cross (60 days) | Death, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Feb 2020 | USD 1.8279 |
| 7 Nov 2019 | USD 1.8279 |
| 8 Aug 2019 | USD 1.8279 |
| 9 May 2019 | USD 1.8279 |
| 7 Feb 2019 | USD 1.8279 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.